These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31578760)

  • 21. Nested Markov compliance class model in the presence of time-varying noncompliance.
    Lin JY; Ten Have TR; Elliott MR
    Biometrics; 2009 Jun; 65(2):505-13. PubMed ID: 18759831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.
    McNamee R
    Stat Med; 2009 Sep; 28(21):2639-52. PubMed ID: 19579227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robustness of parameter and standard error estimates against ignoring a contextual effect of a subject-level covariate in cluster-randomized trials.
    Korendijk EJ; Hox JJ; Moerbeek M; Maas CJ
    Behav Res Methods; 2011 Dec; 43(4):1003-13. PubMed ID: 21512874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-parametric bootstrap confidence intervals for the intraclass correlation coefficient.
    Ukoumunne OC; Davison AC; Gulliford MC; Chinn S
    Stat Med; 2003 Dec; 22(24):3805-21. PubMed ID: 14673940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weighting in instrumental variables and G-estimation.
    Joffe MM; Brensinger C
    Stat Med; 2003 Apr; 22(8):1285-303. PubMed ID: 12687655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating efficacy in clinical trials with clustered binary responses.
    Albert JM
    Stat Med; 2002 Mar; 21(5):649-61. PubMed ID: 11870807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian evaluation of informative hypotheses in cluster-randomized trials.
    Moerbeek M
    Behav Res Methods; 2019 Feb; 51(1):126-137. PubMed ID: 30350025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A score test for binary data with patient non-compliance.
    Branson M; Whitehead J
    Stat Med; 2003 Oct; 22(20):3115-32. PubMed ID: 14518018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design.
    Pate A; Candlish J; Sperrin M; Van Staa TP;
    BMC Med Res Methodol; 2016 Aug; 16(1):109. PubMed ID: 27566594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repairing the efficiency loss due to varying cluster sizes in two-level two-armed randomized trials with heterogeneous clustering.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2016 May; 35(12):2000-15. PubMed ID: 26756696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accounting for correlation and compliance in cluster randomized trials.
    Loeys T; Vansteelandt S; Goetghebeur E
    Stat Med; 2001 Dec; 20(24):3753-67. PubMed ID: 11782031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cluster randomized trials with treatment noncompliance.
    Jo B; Asparouhov T; Muthén BO; Ialongo NS; Brown CH
    Psychol Methods; 2008 Mar; 13(1):1-18. PubMed ID: 18331150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.